ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
83.645
0.13%
US Dollar vs AUD
1.53292
0.13%
Bitcoin
58,802.76
0.97%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Navidea Biopharmaceuticals Inc (NAVB)

  7. Navidea Biopharmaceuticals Inc (NAVB) News

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.0779 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.0779
more quote information »

Recent News

Date Time Source Heading
22/12/202307:32EDGAR2Form SC 13D/A - General statement of acquisition of..
06/12/202310:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202303:49EDGAR2Form 8-K - Current report
17/11/202308:55EDGAR2Form 8-K - Current report
24/10/202304:56EDGAR2Form 25-NSE - Notification filed by national security..
06/10/202312:01BWNavidea Biopharmaceuticals, Inc. Announces NYSE American’s..
06/10/202307:21EDGAR2Form DEF 14A - Other definitive proxy statements
16/9/202305:42EDGAR2Form PRE 14A - Other preliminary proxy statements
11/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
16/8/202307:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/8/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:29BWNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing..
09/8/202306:23EDGAR2Form 8-K - Current report
31/7/202323:32BWNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces..
29/7/202310:23BWNavidea Biopharmaceuticals, Inc. Announces NYSE American Has..
29/7/202307:10EDGAR2Form 8-K - Current report
28/7/202307:20BWNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as..
18/7/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202308:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/7/202307:27EDGAR2Form 8-K - Current report
14/7/202307:09BWNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to..
07/7/202306:39EDGAR2Form 8-K - Current report
04/7/202307:30EDGAR2Form DEF 14A - Other definitive proxy statements
04/7/202306:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/7/202306:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/7/202300:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202323:16BWNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer..
17/6/202306:54BWNavidea Biopharmaceuticals, Inc. Announces Distribution of..
17/6/202303:52BWNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash..
08/6/202306:00BWNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023..
03/6/202307:54BWNavidea Biopharmaceuticals, Inc. Receives NYSE American..
02/6/202307:53BWNavidea Biopharmaceuticals, Inc. Welcomes Jill Bieker..
23/5/202308:30BWNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1..
12/5/202307:35BWNavidea Biopharmaceuticals, Inc. Promotes Michael Sherman..
09/5/202306:12BWNavidea Biopharmaceuticals, Inc. Drives Strategy Forward,..

Your Recent History

AMEX
NAVB
Navidea Biopharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved